EGFR and non-small cell lung carcinoma: In addition to protein overexpression, EGFR is commonly somatically mutated in close to 40% of adenocarcinomas and 30% of adenosquamous NSCLC (mutations occurring ~50% of nonsmokers and 5–15% smokers) [79–81].